Think of glutathione as a glycine-cysteine-glutamic acid chain that your body strings together in a two-step process
In rats, they triggered stomach ulcers three separate ways with stress, with a chemical called cysteamine, and with almost pure alcohol and BPC-157 protected against all three
S-Adenosylmethionine and methylation
Administered through subcutaneous injections, BPC-157 is known for its significant role in tendon healing and pain reduction
Retatrutide should reduce your drive to eat and help you feel satisfied with smaller portions

Cash-pay telehealth weight loss was the early model (companies like Ro, Hims, Calibrate): Monthly membership fee ($50-200) Plus cost of medication (either marked up through compounding pharmacies or retail GLP-1s) Patients pay out of pocket entirely Pros: No insurance billing hassle Higher margins per patient if you mark up medications Cons: Limited to affluent patients High churn when patients cant afford $300-500/month ongoing Regulatory scrutiny (many compounded semaglutide products were investigated for safety) Insurance-based model is becoming more viable: Bill insurance for visits (E/M codes) Send GLP-1 prescription to patients pharmacy (they use insurance for medication) You get paid per visit (~$100-150), patient pays copay Pros: Larger addressable market (anyone with obesity diagnosis and insurance) More sustainable (patients can afford to stay on therapy long-term) Less regulatory risk (using FDA-approved products through licensed pharmacies) Cons: Prior authorization burden Payment delays from insurers Need credentialing with multiple payers Hybrid approach: Some practices bill insurance when possible, offer cash-pay as backup for patients with exclusions
